Insider Transactions Reported by 21 Insiders of eFFECTOR Therapeutics, Inc.

Symbol
EFTR on OTC
Location
Solana Beach, CA

There are no Buy or Sell transactions made by insiders since 27 Jan 2025

eFFECTOR Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Abingworth LLP 10%+ Owner $2,924,612 06 Oct 2021
Carlyle Group Inc. 10%+ Owner $2,924,612 01 Aug 2022
JONATHAN D. ROOT Director, 10%+ Owner $2,744,147 02 Dec 2021
Column Group II GP, LP 10%+ Owner $2,613,608 25 Aug 2021
Presidio Management Group X LLC 10%+ Owner $2,492,418 01 Aug 2022
Locust Walk Sponsor, LLC 10%+ Owner $2,460,116 25 Aug 2021
SR ONE CAPITAL MANAGEMENT, LLC 10%+ Owner $1,104,688 27 Nov 2023
STEPHEN T. WORLAND Chief Executive Officer, Director $58,883 15 May 2024
Alana B. McNulty Chief Business Officer $29,578 20 Jun 2022
Caroline M. Loewy Director $5,487 13 Jun 2024
Michael Byrnes Chief Financial Officer $5,246 15 May 2024
Premal Patel Chief Medical Officer 20 Jan 2022
Elizabeth Bhatt Director 13 Jun 2024
Kristen Harrington-Smith Director 13 Jun 2024
Barbara Klencke Director 13 Jun 2024
Brian M. Gallagher Jr. Director 13 Jun 2024
Douglas J. Warner Chief Medical Officer 19 Feb 2024
Mayank Gandhi Chief Business Officer 17 Jan 2023
John W. Smither Director 22 Jun 2023
Christopher B. Ehrlich Director 13 Jun 2024
Laurence Lasky Director 06 Oct 2021

Recent Insider Transactions by Companies or Individuals for eFFECTOR Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.